Scientific Posters , Molecular Envelope Technology (MET) , OC134 , Double-blind Phase 1

The Sunlight Trial: A Double-blind Phase 1 Safety and Tolerability Clinical Trial of OC134 and MET Eye Drops

20 October 2025
  • Home
  • Resources
  • The Sunlight Trial: A Double-blind Phase 1 Safety and Tolerability Clinical Trial of OC134 and MET Eye Drops
Overview

The objective was to investigate the safety and tolerability of MET 1% and OC134 0.01% in healthy
volunteers and to investigate blood exposure of the drug from topical ocular OC134 0.01% in healthy subjects.

 

 

 

 

Download
Date
20 October 2025